Prudential Financial’s Cabaletta Bio CABA Stock Holding History

Prudential Financial’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-284,000	Closed	-$432K	–	2436
2025 Q2	$432K	Sell	284,000 -3,490	-1%	-$5.44K	﹤0.01%	1980
2025 Q1	$398K	Buy	287,490 +680	+0.2%	+$1.45K	﹤0.01%	1912
2024 Q4	$651K	Hold	286,810	–	–	﹤0.01%	1737
2024 Q3	$1.35M	Hold	286,810	–	–	﹤0.01%	1726
2024 Q2	$2.15M	Buy	286,810 +217,590	+314%	+$2.67M	﹤0.01%	1390
2024 Q1	$1.18M	Hold	69,220	–	–	﹤0.01%	1739
2023 Q4	$1.57M	Sell	69,220 -118,000	-63%	-$1.98M	﹤0.01%	1587
2023 Q3	$2.85M	Buy	187,220 +465	+0.2%	+$6.36K	﹤0.01%	1168
2023 Q2	$2.41M	Buy	+186,755	New	+$2.03M	﹤0.01%	1293

Other funds holding CABA

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

HCM

Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Superstring Capital Management New York $140M AUM 323.19% 1-Year Est. Return

Prudential Financial's CABA Position: Q3 2025 in Review

Prudential Financial sold out of Cabaletta Bio (CABA) in Q3 2025, closing a stake of 284,000 shares — an estimated $432K sold.

Prudential Financial first reported a position in CABA in Q2 2023 and held it in 9 quarters. The position peaked at $2.85M in Q3 2023. 75 funds tracked by Wall St. Rank hold CABA as of Q3 2025.

Prudential Financial reported no remaining Cabaletta Bio position as of Q3 2025 after selling out during the quarter.
Prudential Financial sold 284,000 Cabaletta Bio shares in Q3 2025, an estimated $432K.
Prudential Financial first reported a position in Cabaletta Bio in Q2 2023 and held it in 9 quarters.
Prudential Financial's Cabaletta Bio position peaked at $2.85M in Q3 2023.
75 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2025.

Based on Prudential Financial's 13F filing for Q3 2025, filed 13 Nov 2025.